Previous 10 | Next 10 |
Exact Sciences schedules third quarter 2023 earnings call PR Newswire MADISON, Wis. , Oct. 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release ...
2023-10-08 07:30:00 ET Exact Sciences (NASDAQ: EXAS) and Guardant Health (NASDAQ: GH) make diagnostic tests to help screen for cancer. The two healthcare stocks have similar price-to-sales (P/S) ratios, and over the past five years, nearly identical high-growth profiles....
2023-10-02 10:45:00 ET Ark Invest CEO Cathie Wood is the ultimate thematic investor. Her flagship fund, Ark Innovation ETF focuses on disruptive new technologies such as artificial intelligence (AI), autonomous vehicles, genomic medicine, molecular diagnostics, and cutting-edge medical ...
2023-10-01 16:02:12 ET Bernstein is bullish on medtech stocks Thermo Fisher, Guardant Health, Revvity and PacBio, but sees further downside for Illumina, according to a new industry note. The investment firm kicked off coverage of the US life science tools and diagnostics sector last we...
2023-09-27 09:45:00 ET No investor, no matter how savvy or experienced, gets it right every time. But over the years, some do become successful and recognized after displaying above-average stock-picking abilities. Cathie Wood is such an example. The famed CEO of Ark Invest, an investment f...
2023-09-12 10:42:36 ET More on Agilent Technologies, Exact Sciences Exact Sciences: Adjusting My Strategy After Encouraging Q2 Earnings Exact Sciences: Revolutionizing Cancer Detection With Innovation Agilent Technologies: Solid Operational Performance Paves The...
Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more complete cancer treatment solution for patients, healthcare professionals, and biopharma partners Agilent Technologies, Inc. (NYSE: A) and Exact Sci...
2023-09-06 11:21:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips I disagree with Cathie Wood’s stock picks much if not most of the time. For example, I believe that her huge bullishness on Bitcoin ( BTC-USD ) is completel...
Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials PR Newswire ComboMATCH trials will use Exact Sciences' new OncoExTra ™ therapy selection test to analyze tumor samples for participants in this large preci...
Not a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-Olds Are Avoiding Colorectal Cancer Screenings PR Newswire First-of-its-kind research from the "I Am 45" poll explores why 45-year-olds are not getting screened for deadly colorectal cancer despite national scre...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 08:30:00 ET To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the healthcare company still has some fans on Wall Street. Cathie Wood ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the close of the U.S. financial markets on July 31, 2024. Following the release, company management w...